免疫印迹法在实验大鼠汉坦病毒监测中的应用及与间接免疫荧光法之比较

用汉坦病毒汉滩株（７６－１１８）重组核蛋白作为免疫印迹法（ＷｅｓｔｅｒｎＢｌｏｔ以下简称ＷＢ）的诊断抗原,用于实验感染大鼠血清抗体效价测定。同时与用汉城株（ＳＲ－１１）感染的Ｖｅｒｏ－Ｅ６细胞作抗原的间接免疫荧光法（以下简称ＩＦＡ）进行比较。ＷＢ法对３／４标本在大鼠接种病毒后第３天测得血清ＩｇＭ阳性,而ＩＦＡ法仅１／４标本出现阳性,ＩＦＡ效价为１：５１２０的血清,ＷＢ效价为１’：４０９６０,且在血清１：１０稀释时反应带亦清晰。两种方法分别测定６４份大鼠血清。甩ＩＦＡ法,４４份（６８．８％）出现类似阳性的荧光颗粒,而用ＷＢ法测定,无特异的反应带出现。非感染Ｖｅｒｏ－Ｅ６细胞作ＩＦＡ抗原,３０份（４６．９％）与正常细胞抗原有反应,此结果表明ＷＢ法在特异性和敏感性方面均高于ＩＦＡ法。ＩＦＡ法中的非特异性反应系血清与细胞成份之反应。     

猴B病毒相关抗体及B病毒抗体检测的比较研究

本文比较了用ＨＳＶ－１（ＩＥＡ）和Ｂ病毒（ＩＦＡ）的方法检查猴Ｂ病毒相关抗体和Ｂ病毒抗体的结果：ＩＥＡ检查出的Ｂ病毒相关抗体阴性猴,经ＩＦＡ检查,全部为Ｂ病毒抗体阴性。用ＩＦＡ检查了Ｂ病毒相关抗体阴性的恒河猴,在单笼隔离饲养六个月后,有９８．３％的动物Ｂ病毒相关抗体仍为阴性,表明ＩＲＡ的阴性结果有较好的一致性。本文讨论了建立无Ｂ病毒感染猴群的可行性。     

人肝癌细胞的IGF—BP1分子特性及内源性蛋白酶对其降解的研究

用ＳＤＳ－ＰＡＧＥ电泳、高效液相色谱（ＨＰＬＣ）、质谱等方法,研究了人肝癌细胞（ＨｅｐＧ２）分泌的胰岛素样生长因子结合蛋白－１（＾３５Ｓ－ＩＧＦ－ＢＰ１）的分子结构、特性,及其被内源性蛋白酶降解的特点,＾３５Ｓ－ＩＧＦ－ＢＰ１的经抗体免疫沉淀、生化分离,纯化为均一体,其分子是由多个亚构成的蛋白质,分子量约为２７ｋＤ;细胞ＵＭＲ、ＨｅｐＧ２、Ｈ３５ＢＲＬ３Ａ分泌的蛋白酶能将＾３５Ｓ－ＩＧＦ－ＢＰ１催     

中国黄耆属一新种

中国黄耆属一新种朱相云,陈家瑞（中国科学院植物研究所,北京１０００－９３）ＡＮＥＷＳＰＥＣＩＥＳＯＦＡＳＴＲＡＧＡＬＵＳ（ＬＥＧＵＭＩＮＯＳＡＥ）ＦＲＯＭＣＨＩＮＡ￥ＺｈｕＸｉａｎｇｙｕｎａｎｄＣｈｅｎＣｈｉａｒｕｉ（ＩｎｓｔｉｔｕｔｅｏｆＢｏｔａｎ...     

蝮蛇抗栓酶对不稳定性心绞痛患者血中部分凝血及纤溶指标的影响

测定３８例不稳定性心绞痛（ＵＡＰ）患者血中纤维蛋白原（Ｆｇ）含量、组织型纤溶酶原激活物（ｔ－ＰＡ）活性、血管性假血友病因子（ｖＷＦ）活性和血小板聚集率水平（ＰＡｇＴ）并与２１名正常人对比。患者中１８例用蝮蛇抗栓酶治疗,２０例行常规治疗。结果显示：ＵＡＰ患者血中ＰＡＩ－１、ｖＷＦ以及ＰＡｇＴ水平明显增高,ｔ－ＰＡ水平明显降低;蝮蛇抗栓酶组治疗后血中Ｆｇ、ＰＡＩ－１、ＰＡｇＴ水平均明显下降,使ｔ－ＰＡ水平明显升高;常规治疗组治疗前后各项指标无明显变化。认为蝮蛇抗栓酶对ＵＡＰ有可靠疗效     

全球红树林区系地理

全球红树林区系地理缪绅裕陈桂珠（广州师范学院生物系,广州５１０４００）（中山大学环科所,广州５１０２７５）ＦＬＯＲＡＡＮＤＤＩＳＴＲＩＢＵＴＩＶＥＰＡＴＴＥＲＮＳＯＦＭＡＮＧＲＯＶＥＩＮＴＨＥＷＯＲＬＤＭｉａｏＳｈｅｎ－ｙｕ（Ｄｅｐａｒｔｍｅｎｔｏｆ...     

云南漆树属一新种

云南漆树属一新种陈振峰，闵天禄（商业部西安生漆研究所，西安７１００６１）（中国科学院昆明植物研究所，昆明６５０２０４）关键词喙果漆ＡＮＥＷＳＰＥＣＩＥＳＯＦＴＨＥＧＥＮＵＳＴＯＸＩＣＯＤＥＮＤＲＯＮＦＲＯＭＹＵＮＮＡＮ￥ＣＨＥＮＺｈｅｎ－Ｆｅｎｇ１，...     

云南黄芪属二新种

云南黄芪属二新种＊钱子刚１陈介２（１云南中医学院，昆明６５００１１）（２中国科学院昆明植物研究所，昆明６５０２０４）ＴＷＯＮＥＷＳＰＥＣＩＥＳＯＦＡＳＴＲＡＧＡＬＵＳＦＲＯＭＹＵＮＮＡＮＱｉａｎＺｉｇａｎｇ１，ＣｈｅｎＪｉｅ（ＣｈｅｎＣｈｅｉｈ）２（...     

人免疫缺陷病毒1型Rev单链抗体细胞内免疫抗病毒基因治疗研究

应用抗ＨＩＶ－１Ｒｅｖ单链抗体细胞内免疫方法,研究在人Ｔ细胞和周围血淋巴单核细胞内抗病毒复制的效果,探讨细胞内免疫抗ＨＩＶ－１基因治疗的可行性。克隆抗ＨＩＶ－１Ｒｅｖ单链抗抗体（ｓＦｖ）基因,以逆转录病毒为基因载体,将名装后的含靶基因的逆转录病毒转导至人ＣＤ４阳性Ｔ－细胞株ＣＥＭ和ＳｕｐＴ１,以及ＨＩＶ－１阴性自愿者的周围血淋巴单核细胞（ＰＢＭＣ）,再分别用不同剂量（ＭＯＩ）的ＨＩＶ－１病毒株ＰＮ     

植物种群分布格局研究概况

植物种群分布格局研究概况李海涛（中国科学院植物研究所,北京１０００４４）ＩＮＴＲＯＤＵＣＴＩＯＮＴＯＳＴＵＤＩＥＳＯＦＴＨＥＰＡＴＴＥＲＮＯＦＰＬＡＮＴＰＯＰＵＬＡＴＩＯＮＬｉＨａｉ－ｔａｏ（ＩｎｓｔｉｔｕｔｅｏｆＢｏｔａｎｙ,ＡｃａｄｅｍｉａＳｉｎ...     

Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response

B. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax) consists of aluminum-adsorbed cell-free filtrates of unencapsulated B. anthracis, wherein PA is thought to be the principle target of neutralization. In this study, we evaluated the efficacy of the natural adjuvant, C3d, versus alum in eliciting an anti-PA humoral response and found that C3d conjugation to PA and emulsion in incomplete Freund's adjuvant (IFA) imparted superior protection from anthrax challenge relative to PA in IFA or PA adsorbed to alum. Relative to alum-PA, immunization of mice with C3d-PA/IFA augmented both the onset and sustained production of PA-specific antibodies, including neutralizing antibodies to the receptor-binding portion (domain 4) of PA. C3d-PA/IFA was efficacious when administered either i.p. or s.c., and in adolescent mice lacking a fully mature B cell compartment. Induction of PA-specific antibodies by C3d-PA/IFA correlated with increased efficiency of germinal center formation and plasma cell generation. Importantly, C3d-PA immunization effectively protected mice from intranasal challenge with B. anthracis spores, and was approximately 10-fold more effective than alum-PA immunization or PA/IFA based on dose challenge. These data suggest that incorporation of C3d as an adjuvant may overcome shortcomings of the currently licensed aluminum-based vaccine, and may confer protection in the early days following acute anthrax exposure.     

Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection

Acute human parvovirus B19 infection is followed by an antibody response to the structural proteins of the viral capsid (VP1 and VP2). We used 80 sera collected from 58 erythema infectiosum and 6 transient aplastic crisis patients to test IgM and IgG antibodies against these two proteins in an immunofluorescence assay (IFA) using Sf9 cells infected with recombinant baculovirus expressing either VP1 or VP2 antigen. Although less sensitive than IgM capture enzyme immunoassay using native antigen (MACEIA), we could detect anti-VP1 or anti-VP2 IgM antibodies by IFA in 49 patients with acute infection (76.6%). Detection of IgG anti-VP1 and anti-VP2 by IFA, however, was as sensitive as IgG detection by indirect enzyme immunoassay. By applying IgG avidity IFA to sera of the 15 IgM IFA negative patients we were able to confirm acute infection in further 12 cases by IFA. Overall, acute infection was confirmed by IFA in 61 (95.3%) of the 64 patients.     

Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.

As the study of type 1 diabetes moves towards preventive therapy, the role of adjuvants needs to be addressed. Incomplete Freund's adjuvant (IFA) is thought of as "immunologically inert" as, unlike complete FA (CFA), it has no components designed to provoke an immune response. We investigated the effect of IFA as an immunomodulator on the disease process leading to type 1 diabetes in the non-obese diabetic (NOD) mouse. 24 NOD mice were injected intradermally (i.d.) at 8 and 12 weeks of age with a 1:1 mixture of IFA and saline; 24 controls received saline alone. Splenocytes were tested against antigens thought to be involved in the disease process, namely insulin, a GAD peptide, a beta-casein peptide, a Glut-2 peptide and concanavalin A (ConA) as a non-specific antigen. In the IFA experiment diabetes incidence was 13% compared to 38% in the controls (p < 0.05). In vitro, splenocytes from IFA treated animals showed non-specific immunosuppression with ConA (p < 0.01), whereas the response to 1-casein and Glut-2 was raised in IFA treated animals with respect to controls. ELISA using supernatants from IFA treated animals, showed a typical Th2 cytokine pattern, whereas controls showed a Th1 pattern. In conclusion, IFA alone can reduce diabetes incidence in the NOD mouse apparently by modulating the immune response towards beta-cell related specific antigens. As IFA has been adopted as an adjuvant in preventive trials in the NOD mouse, this might have implications for the interpretation of previous and future results.     

12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoic acid: biological recognition by cholesterol esterase and acyl-CoA:cholesterol O-acyltransferase

Potential probes of protein cholesterol and fatty acid binding sites, namely, 12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoate (IFA) and its coenzyme A (IFA:CoA) and cholesteryl (IFA:CEA) esters, were synthesized. These radioactive, photoreactive lipid analogues were recognized as substrates and inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) and cholesterol esterase, neutral lipid binding enzymes which are key elements in the regulation of cellular cholesterol metabolism. In the dark, IFA reversibly inhibited cholesteryl [14C]oleate hydrolysis by purified bovine pancreatic cholesterol esterase with an apparent Ki of 150 microM. Cholesterol esterase inhibition by IFA became irreversible after photolysis with UV light and oleic acid (1 mM) provided 50% protection against inactivation. Incubation of homogeneous bovine pancreatic cholesterol esterase with IFA:CEA resulted in its hydrolysis to IFA and cholesterol, indicating recognition of IFA:CEA as a substrate by cholesterol esterase. The coenzyme A ester, IFA:CoA, was a reversible inhibitor of microsomal ACAT activity under dark conditions (apparent Ki = 20 microM), and photolysis resulted in irreversible inhibition of enzyme activity with 87% efficiency. IFA:CoA was also recognized as a substrate by both liver and aortic microsomal ACATs, with resultant synthesis of 125IFA:CEA. IFA and its derivatives, IFA:CEA and IFA:CoA, are thus inhibitors and substrates for cholesterol esterase and ACAT. Biological recognition of these photoaffinity lipid analogues will facilitate the identification and structural analysis of hitherto uncharacterized protein lipid binding sites.     

Characterisation of the protective immune response following subcutaneous vaccination of susceptible mice against Trichuris muris

Trichuris muris is a laboratory model for the human whipworm Trichuris trichiura which infects approximately 1 billion people in tropical and sub-tropical countries. The development of a vaccine would control trichuriasis by promoting the acquisition of immunity during childhood, thereby reducing faecal egg output by the community into their environment. Resistance to T. muris, defined as expulsion of the parasite prior to patency, requires the development of a T helper 2 (Th2) response during a primary infection. To our knowledge this is the first study to describe the protective immune response in the peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN) and colonic mucosa following s.c. vaccination against T. muris. Susceptible AKR mice were either vaccinated with T. muris excretory-secretory product (ES) in incomplete Freund’s adjuvant (IFA) (ES/IFA) or injected with PBS in IFA (PBS/IFA) and for protection experiments were infected with embryonated infective T. muris eggs 10 days later. The ES/IFA vaccine induced the proliferation of PLN cells and their production of Th2 cytokines and the Th1-associated cytokine IFN-γ. Following a challenge infection, the ES/IFA vaccination offered susceptible mice complete protection. While MLN-derived IFN-γ was produced by infected mice following either ES/IFA vaccination or PBS/IFA, the protection of susceptible mice by ES/IFA was characterised by the production of MLN-derived Th2 cytokines. Goblet cell hyperplasia and the influx and alternative activation of macrophages were observed locally in the gut post-challenge infection. The rate of epithelial turnover did not appear to be increased by vaccination, suggesting that there are differences in the mechanisms of expulsion between ‘natural resistance’ and ‘vaccinated resistance’. High levels of serum IgG1 and cell-bound IgG1 in the colon of mice protected by the ES/IFA vaccine suggest that antibody may be involved in vaccination-induced worm expulsion.     

Serological survey for two simian retroviruses in macaques and African green monkeys

Colonies of nonhuman primates at the Bowman Gray School of Medicine (BGSM) were tested for antibodies to two retroviruses associated with immunodeficiency by indirect immunofluorescence (IFA) and western blot. A total of 471 cynomolgus macaques (Macaca fascicularis), 144 rhesus monkeys (M. mulatta) and 67 stumptail monkey M. arctoides) were tested for SRV-1, and 152 African green monkeys (Cercopithecus aethiops) were tested for SIV. Of the macaques tested, 170 (36%) cynomolgus, 5 (3%) rhesus and 8 (12%) stumptails were positive for SRV-1 antibodies by IFA. Of the African green monkeys, 54 (36%) were IFA positive for SIV antibodies. A total of 143 African green monkeys tested by IFA also were tested by western blot. In the African green monkeys, the IFA had a positive predictive value of 98% and a negative predictive value of 96%. Of 176 IFA positive macaque sera tested by western blot, 49 (28%) were positive, 55 (31%) were considered equivocal (only one band, usually to p27 core protein), and 72 (41%) were negative.     

Evaluation of indirect fluorescent antibody assays compared to rapid influenza diagnostic tests for the detection of pandemic influenza A (H1N1) pdm09

Performance of indirect fluorescent antibody (IFA) assays and rapid influenza diagnostic tests (RIDT) during the 2009 H1N1 pandemic was evaluated, along with the relative effects of age and illness severity on test accuracy. Clinicians and laboratories submitted specimens on patients with respiratory illness to public health from April to mid October 2009 for polymerase chain reaction (PCR) testing as part of pandemic H1N1 surveillance efforts in Orange County, CA; IFA and RIDT were performed in clinical settings. Sensitivity and specificity for detection of the 2009 pandemic H1N1 strain, now officially named influenza A(H1N1)pdm09, were calculated for 638 specimens. Overall, approximately 30% of IFA tests and RIDTs tested by PCR were falsely negative (sensitivity 71% and 69%, respectively). Sensitivity of RIDT ranged from 45% to 84% depending on severity and age of patients. In hospitalized children, sensitivity of IFA (75%) was similar to RIDT (84%). Specificity of tests performed on hospitalized children was 94% for IFA and 80% for RIDT. Overall sensitivity of RIDT in this study was comparable to previously published studies on pandemic H1N1 influenza and sensitivity of IFA was similar to what has been reported in children for seasonal influenza. Both diagnostic tests produced a high number of false negatives and should not be used to rule out influenza infection.     

Detection of Gardnerella vaginalis on vaginal smears by immunofluorescence

An indirect fluorescence antibody (IFA) test was developed for the detection of Gardnerella vaginalis. Antisera were prepared in rabbits by using five strains of G. vaginalis. A pool of the antisera was tested for specificity with a variety of isolates known to colonize the human vagina and (or) morphologically resemble G. vaginalis. Six heterologous bacterial isolates reacted with the pooled antiserum at dilutions of 1:10, but none reacted at the working dilution of 1:200. Vaginal swab specimens were collected from symptomatic and asymptomatic patients in order to further evaluate the IFA procedure. The presence of G. vaginalis in the specimens was determined both by culture and by the IFA procedure. Absorbed antisera reacted with all isolates of G. vaginalis tested. In a clinical trial the IFA procedure detected the presence of G. vaginalis in smears from 23 (24.2%) of the patients with nonspecific vaginitis (NSV), from 22 (29.8%) of the asymptomatic individuals tested, and from 3 patients with vaginitis other than NSV. The presence of G. vaginalis in smears as detected by the IFA procedure was confirmed by cultures in all cases using Vaginalis agar supplemented with colistin and nalidixic acid (V-CNA). It is suggested that the IFA procedure may be of use in conjunction with V-CNA in epidemiological studies of the carriage and transmission of G. vaginalis in human populations. It appears that the IFA procedure, at least in our hands, is a useful test for the rapid detection of G. vaginalis even when this microorganism is not the predominant colonizer of the human vagina.     

Polymerase chain reaction for the detection of Cryptosporidium spp. in cat feces

The objective of this study was to compare a polymerase chain reaction (PCR) assay and a monoclonal antibody-based immunofluorescence assay (IFA) for detection of Cryptosporidium parvum in cat feces. Eight C. parvum-naive DSH cats were orally inoculated with 1 x 10(6) oocysts of a C. parvum human isolate. Fecal samples were collected before inoculation, daily for the next 30 days, and twice weekly until day 85. Methylprednisolone acetate was administered at 20 mg/kg i.m. on days 85, 92, and 99. From days 86 to 115, feces were collected daily and then up to twice weekly until day 126. Immunofluorescence assay was performed after collection of the samples, and then the samples were frozen at -70 C until assayed by PCR. Cryptosporidium parvum was detected by PCR in 101 of 353 samples and by IFA in 52 of 353 samples: 27 samples were PCR positive, IFA positive; 74 samples were PCR positive, IFA negative; 25 samples were PCR negative, IFA positive; and 227 samples were PCR negative, IFA negative. The percentage of concordance between IFA and PCR was 72%. Results of this study suggest that this PCR assay is more sensitive than IFA for detection of C. parvum in cat feces.     

Serodiagnosis of cilia-associated respiratory bacillus infection by the indirect immunofluorescence assay technique

Antibody to cilia-associated respiratory (CAR) bacillus was detected by the indirect immunofluorescence assay (IFA) technique using tracheal sections of infected mice as antigen in serum samples collected from rats infected naturally and experimentally. Nine of 23 cases of natural infection were positive in IFA antibody, with titres ranging from 1:10 to 1:80, and all these antibody-positive cases were also histologically positive. The remaining 14 cases were negative in both IFA antibody and histological diagnosis, even though some of them were infected with Sendai virus and Mycoplasma pulmonis. In the experimental infection, serum samples collected from 18 rats on days 4, 7, 14, 21, 28 and 56 post-inoculation (PI) (three rats for each point) and examined for IFA antibody revealed that seroconversion occurred in one rat on day 14 PI and in three rats on day 21 PI. Antibody titres of 1:80 to 1:160 remained to the termination of the experiment. The IFA technique was useful for the diagnosis of CAR bacillus infection except in the early stage of the infection.